qPCR for ChIP analysis. Where possible, primers were designed so that amplicons spanned exon junctions. Where shown predicted amplicon sizes was obtained using the in silico PCR program http://genome.ucsc.edu/index.html?org = Hu- man&db = hg18&hgsid = 142437216. (DOC) Acknowledgments We are grateful to John Castle and Jason Johnson (Rosetta Inpharmatics) for helpful discussions and contacts, Emma Clark and Ian Logan References 1. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, et al. (2004) Molecular determinants of resistance to antiandrogen therapy. Nat Med 10: 33–39. 2. Cancer Research UK website. Available: http://info.cancerresearchuk.org/ cancerstats/types/prostate/. Prostate Cancer Statistics - Key Facts. Accessed 2011 Nov 21. 3. Massie CE, Adryan B, Barbosa-Morais NL, Lynch AG, Tran MG, et al. (2007) New androgen receptor genomic targets show an interaction with the ETS1 transcription factor. EMBO Rep 8: 871–878. 4. Massie CE, Lynch A, Ramos-Montoya A, Boren J, Stark R, et al. (2011) The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J 30: 2719–2733. 5. Yap TA, Zivi A, Omlin A, de Bono JS (2011) The changing therapeutic landscape of castration-resistant prostate cancer. Nat Rev Clin Oncol 8: 597–610. 6. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, et al. (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302: 2141–2144. 7. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40: 1413–1415. 8. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470–476. 9. Rajan P, Gaughan L, Dalgliesh C, El-Sherif A, Robson CN, et al. (2008) The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor. J Pathol 215: 67–77. 10. Sun J, Blair AL, Aiyar SE, Li R (2007) Cofactor of BRCA1 modulates androgen- dependent transcription and alternative splicing. J Steroid Biochem Mol Biol 107: 131–139. 11. Auboeuf D, Honig A, Berget SM, O’Malley BW (2002) Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298: 416–419. 12. Clark EL, Coulson A, Dalgliesh C, Rajan P, Nicol SM, et al. (2008) The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res 68: 7938–7946. 13. Dutertre M, Gratadou L, Dardenne E, Germann S, Samaan S, et al. (2010) Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer. Cancer Res 70: 3760–3770. 14. Cochrane DR, Wang Z, Muramaki M, Gleave ME, Nelson CC (2007) Differential regulation of clusterin and its isoforms by androgens in prostate cells. J Biol Chem 282: 2278–2287. 15. Rajan P, Elliott DJ, Robson CN, Leung HY (2009) Alternative splicing and biological heterogeneity in prostate cancer. Nat Rev Urol 6: 454–460. 16. Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, et al. (2002) The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci U S A 99: 11890–11895. 17. Ngan S, Stronach EA, Photiou A, Waxman J, Ali S, et al. (2009) Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells. Oncogene 28: 2051–2063. 18. Velasco AM, Gillis KA, Li Y, Brown EL, Sadler TM, et al. (2004) Identification and validation of novel androgen-regulated genes in prostate cancer. Endocrinology 145: 3913–3924. 19. Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, et al. (2002) Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene 21: 8749–8758. 20. Xu LL, Su YP, Labiche R, Segawa T, Shanmugam N, et al. (2001) Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes. Int J Cancer 92: 322–328. 21. DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, et al. (2002) Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3: RESEARCH0032. 22. Li H, Lovci MT, Kwon YS, Rosenfeld MG, Fu XD, et al. (2008) Determination of tag density required for digital transcriptome analysis: application to an androgen-sensitive prostate cancer model. Proc Natl Acad Sci U S A 105: 20179–20184. Androgen-Dependent Exons (Newcastle University) for assistance with qPCR assays, Liming Wang and Heiko Peters (Newcastle University) for array processing, and Pawel Herzyk (University of Glasgow) and Pierre de la Grange (GenoSplice) for assistance with bioinformatics. Author Contributions Conceived and designed the experiments: PR JS LG HYL DJE. Performed the experiments: PR CD KA JS LG. Analyzed the data: PR PC TB CZ SNG CS GK. Contributed reagents/materials/analysis tools: MQZ CNR HYL DJE. Wrote the paper: PR HYL DJE. 23. Park SI, Zhang J, Phillips KA, Araujo JC, Najjar AM, et al. (2008) Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model. Cancer Res 68: 3323–3333. 24. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Res 12: 996–1006. 25. Stalder L, Muhlemann O (2008) The meaning of nonsense. Trends Cell Biol 18: 315–321. 26. Rahrmann EP, Collier LS, Knutson TP, Doyal ME, Kuslak SL, et al. (2009) Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen. Cancer Res 69: 4388–4397. 27. de la Grange P, Dutertre M, Martin N, Auboeuf D (2005) FAST DB: a website resource for the study of the expression regulation of human gene products. Nucleic Acids Res 33: 4276–4284. 28. Chen HM, Schmeichel KL, Mian IS, Lelievre S, Petersen OW, et al. (2000) AZU-1: a candidate breast tumor suppressor and biomarker for tumor progression. Mol Biol Cell 11: 1357–1367. 29. Gangisetty O, Lauffart B, Sondarva GV, Chelsea DM, Still IH (2004) The transforming acidic coiled coil proteins interact with nuclear histone acetyl- transferases. Oncogene 23: 2559–2563. 30. Kwiatkowski DJ, Manning BD (2005) Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 14 Spec No. 2: R251–258. 31. Inoki K, Guan KL (2009) Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum Mol Genet 18: R94–100. 32. Hinrichs AS, Karolchik D, Baertsch R, Barber GP, Bejerano G, et al. (2006) The UCSC Genome Browser Database: update 2006. Nucleic Acids Res 34: D590–598. 33. Yu Y, Chen B, Chen Z, Fan C, Han Y, et al. (2005) Identification of a novel Wee1 isoform. Biochim Biophys Acta 1729: 1–9. 34. Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, et al. (2010) An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17: 443–454. 35. Xu Y, Chen SY, Ross KN, Balk SP (2006) Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post- transcriptional increases in cyclin D proteins. Cancer Res 66: 7783–7792. 36. Suh Y, Afaq F, Khan N, Johnson JJ, Khusro FH, et al. (2010) Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis 31: 1424–1433. 37. Rosner M, Hanneder M, Siegel N, Valli A, Hengstschlager M (2008) The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutat Res 658: 234–246. 38. Kapur K, Xing Y, Ouyang Z, Wong WH (2007) Exon arrays provide accurate assessments of gene expression. Genome Biol 8: R82. 39. Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, et al. (2009) Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4- dependent migration of prostate cancer cells in vitro. Mol Endocrinol 23: 1385–1396. 40. Affymetrix Inc. website. Available: http://www.affymetrix.com/support/ technical/whitepapers/ Quality Assessment of Exon and Gene Arrays; Exon Array Background Correction; Alternative Transcript Analysis Methods for Exon Arrays; Exon Probeset Annotations and Transcript Cluster Groupings. Accessed 2011 Nov 21. 41. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440–9445. 42. Maglott D, Ostell J, Pruitt KD, Tatusova T (2007) Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 35: D26–31. 43. de la Grange P, Dutertre M, Correa M, Auboeuf D (2007) A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants. BMC Bioinformatics 8: 180. 44. Logan IR, Gaughan L, McCracken SR, Sapountzi V, Leung HY, et al. (2006) Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer. Mol Cell Biol 26: 6502–6510. PLoS ONE | www.plosone.org 13 December 2011 | Volume 6 | Issue 12 | e29088